Ranking Options
Set How Experts Are Ranked
Rating Time Period
Measure the performance of each rating since Jan-2009 for the duration of:
Rating Benchmark
Compare the performance of each rating to:
9

PropThink

Financial Blogger at Seeking Alpha

Main Sector:Healthcare

Ranked #9 out of 5,844 Bloggers

(#23 of 10,343 overall experts)

Main Sector:Healthcare
66%
Success Rate
92 out of 139 successful ratings
+49.3%
Average Return
Average return per recommendation
If you copied PropThink's recommendations since 2012 and opened each position for the duration of 1 Year, then 66% of your transactions would have been profitable with an average return of 49.3% over No Benchmark.

Followed by 242 investors

Stock Coverage

Expand

Novelion Therapeutics Inc
hold
2 years ago
2 years ago
3
Ratings

Affimed
buy
2 years ago
2 years ago
2
Ratings

Cascadian Therapeutics
buy
2 years ago
2 years ago
4
Ratings

GlobeImmune
hold
2 years ago
2 years ago
2
Ratings

Conatus Pharmaceuticals
hold
2 years ago
2 years ago
2
Ratings

Ironwood Pharma
buy
3 years ago
3 years ago
1
Ratings

Albany Molecular Research
buy
3 years ago
3 years ago
2
Ratings

Acorda Therapeutics
buy
3 years ago
3 years ago
2
Ratings

Emergent Biosolutions
buy
3 years ago
3 years ago
1
Ratings
XNPT
XenoPort
buy
3 years ago
3 years ago
1
Ratings

Cempra Inc
buy
3 years ago
3 years ago
2
Ratings
PCYC
Pharmacyclics
buy
3 years ago
3 years ago
4
Ratings
CBST
Cubist Pharma
buy
3 years ago
3 years ago
3
Ratings

BioDelivery
buy
3 years ago
3 years ago
1
Ratings

Zogenix
buy
3 years ago
3 years ago
1
Ratings

Pozen
buy
3 years ago
3 years ago
2
Ratings
VPHM
Viropharma
buy
3 years ago
3 years ago
2
Ratings

Shire
buy
3 years ago
3 years ago
1
Ratings

Keryx Biopharma
buy
3 years ago
3 years ago
8
Ratings

Durect Corp
buy
3 years ago
3 years ago
3
Ratings

Neuralstem
buy
3 years ago
3 years ago
2
Ratings

Illumina
buy
3 years ago
3 years ago
5
Ratings
ZLCS
Zalicus Inc
buy
3 years ago
3 years ago
1
Ratings

Vivus
buy
3 years ago
3 years ago
1
Ratings
QCOR
Questcor
buy
3 years ago
3 years ago
5
Ratings

Endocyte
buy
3 years ago
3 years ago
1
Ratings

Depomed
buy
4 years ago
4 years ago
3
Ratings

Sunshine Heart
buy
4 years ago
4 years ago
2
Ratings

ChemoCentryx
buy
4 years ago
4 years ago
1
Ratings

BioCryst
sell
4 years ago
4 years ago
1
Ratings

Enanta Pharmaceuticals
buy
4 years ago
4 years ago
2
Ratings

Neurocrine
buy
4 years ago
4 years ago
1
Ratings

Tengion Inc
sell
4 years ago
4 years ago
1
Ratings

Incyte Corp
buy
4 years ago
4 years ago
1
Ratings

Curis Inc
buy
4 years ago
4 years ago
1
Ratings

Achillion Pharmaceuticals
buy
4 years ago
4 years ago
1
Ratings
GEVA
Synageva
buy
4 years ago
4 years ago
1
Ratings
TTHI
Transition Therapeutics
buy
4 years ago
4 years ago
2
Ratings

Infinity Pharma
buy
4 years ago
4 years ago
1
Ratings

Resmed Inc
sell
4 years ago
4 years ago
2
Ratings

Sarepta Therap
buy
4 years ago
4 years ago
2
Ratings

Stemline
buy
4 years ago
4 years ago
1
Ratings

Synergy Pharma
buy
4 years ago
4 years ago
2
Ratings

Regeneron
buy
4 years ago
4 years ago
1
Ratings

Vical Inc
buy
4 years ago
4 years ago
1
Ratings
TSRX
Trius Therap
buy
4 years ago
4 years ago
1
Ratings

Alexion Pharmaceuticals
buy
4 years ago
4 years ago
2
Ratings

Arbutus Biopharma
buy
4 years ago
4 years ago
1
Ratings

Intercept Pharma
sell
4 years ago
4 years ago
1
Ratings
DARA
DARA Biosciences
buy
4 years ago
4 years ago
2
Ratings

Navidea
buy
4 years ago
4 years ago
2
Ratings
ASTX
Astex Pharmaceuticals
buy
4 years ago
4 years ago
1
Ratings

Immunomedics
buy
4 years ago
4 years ago
2
Ratings

Madrigal Pharmaceuticals Inc
buy
4 years ago
4 years ago
1
Ratings

BioMarin
buy
4 years ago
4 years ago
2
Ratings

Halozyme
buy
4 years ago
4 years ago
3
Ratings

Orasure Technologies
buy
4 years ago
4 years ago
1
Ratings

Amedisys
sell
4 years ago
4 years ago
2
Ratings

ACADIA Pharmaceuticals
buy
4 years ago
4 years ago
3
Ratings

OHR Pharmaceutical
buy
4 years ago
4 years ago
1
Ratings

Delcath Systems
buy
4 years ago
4 years ago
1
Ratings

ImmunoCellular Therapeutics
buy
4 years ago
4 years ago
1
Ratings

Ionis Pharmaceuticals Inc
buy
4 years ago
4 years ago
2
Ratings
OPTR
Optimer Pharma
sell
4 years ago
4 years ago
1
Ratings

Raptor Pharma
buy
4 years ago
4 years ago
2
Ratings

Biogen Inc
buy
4 years ago
4 years ago
1
Ratings

Affymax
sell
4 years ago
4 years ago
2
Ratings
ITMN
InterMune
buy
4 years ago
4 years ago
1
Ratings

Sangamo Biosciences
buy
4 years ago
4 years ago
1
Ratings

Sciclone Pharmaceuticals
buy
4 years ago
4 years ago
2
Ratings

Pharmathene Inc
buy
4 years ago
4 years ago
1
Ratings

Endo International
buy
4 years ago
4 years ago
2
Ratings

AVEO Pharma
buy
4 years ago
4 years ago
1
Ratings

Orexigen
buy
4 years ago
4 years ago
1
Ratings

Arqule
buy
4 years ago
4 years ago
1
Ratings

Sucampo Pharmaceuticals
buy
4 years ago
4 years ago
1
Ratings

Amarin
sell
4 years ago
4 years ago
1
Ratings

Acelrx
buy
4 years ago
4 years ago
1
Ratings
CHTP
Chelsea Therapeutics
buy
4 years ago
4 years ago
1
Ratings

Alexza Pharmaceuticals
sell
4 years ago
4 years ago
1
Ratings

Teva Pharma
buy
4 years ago
4 years ago
1
Ratings

Anthera Pharmaceuticals
buy
4 years ago
4 years ago
1
Ratings
MRGE
Merge Healthcare
buy
4 years ago
4 years ago
1
Ratings

How We Rank Financial Experts

By tracking and measuring the performance of over 50,000 financial experts, TipRanks is able to identify the top 25 experts within each sector who consistently outperform the markets. Now that we’ve done the work for you and crunched all the data, all you need to do is browse the top experts and follow your favorites to be instantly notified whenever they recommend to buy or sell your stocks.

TipRanks Star RankingTM

TipRanks Star Ranking is calculated based on the combinations of the following factors:

  • Expert Success Rate

    The percentage of an analyst’s ratings resulting in a positive return

  • Expert Average Return

    The average return per expert recommendation

  • Statistical Significance

    The more data we collect on an expert, the more statistically significant his measurement is.